AXSOME THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
AXSOME THERAPEUTICS, INC. (AXSM) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $121.36 million as of 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-02-23
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $121.36M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $120.15M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $114.89M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $96.16M; Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed $96.16M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2025-12-31 | $121.36M 10-K · filed 2026-02-23 | |
| 2024-12-31 | $120.15M 10-K · filed 2026-02-23 | |
| 2023-12-31 | $114.89M 10-K · filed 2025-02-18 | |
| 2022-12-31 | $96.16M 10-K · filed 2024-02-23 | $96.16M 10-K · filed 2023-02-28 |
| 2021-12-31 | $76.47M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $52.33M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $32.30M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $18.91M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $12.84M 10-K · filed 2019-03-15 | |
| 2016-12-31 | $12.75M 10-K · filed 2019-03-15 | |
| 2015-12-31 | $5.28M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |